Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D C Fischer

Showing results (51-60 of 53) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 53 results.
The Journal of Clinical Endocrinology and Metabolism|October 14, 2011
Three-year growth hormone treatment in short children with X-linked hypophosphatemic rickets: effects on linear growth and body disproportionM Živičnjak, D Schnabel, H Staude, et al.
Gynecologic Oncology|December 6, 2001
Adenovirus-mediated thymidine kinase gene therapy in combination with topotecan for patients with recurrent ovarian cancer: 2.5-year follow-upA Hasenburg, X W Tong, D C Fischer, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 28, 2002
Histologic and immunohistochemical analysis of tissue response to adenovirus-mediated herpes simplex thymidine kinase gene therapy of ovarian cancerA Hasenburg, D C Fischer, X-W Tong, et al.
Pageof 6

Showing results (51-60 of 53) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 53 results.
The Journal of Clinical Endocrinology and Metabolism|October 14, 2011
Three-year growth hormone treatment in short children with X-linked hypophosphatemic rickets: effects on linear growth and body disproportionM Živičnjak, D Schnabel, H Staude, et al.
Gynecologic Oncology|December 6, 2001
Adenovirus-mediated thymidine kinase gene therapy in combination with topotecan for patients with recurrent ovarian cancer: 2.5-year follow-upA Hasenburg, X W Tong, D C Fischer, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 28, 2002
Histologic and immunohistochemical analysis of tissue response to adenovirus-mediated herpes simplex thymidine kinase gene therapy of ovarian cancerA Hasenburg, D C Fischer, X-W Tong, et al.
Pageof 6